Literature DB >> 4361439

Inclusion-body beta-thalassemia trait. A form of beta thalassemia producing clinical manifestations in simple heterozygotes.

G Stamatoyannopoulos, R Woodson, T Papayannopoulou, D Heywood, S Kurachi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4361439     DOI： 10.1056/NEJM197404252901705

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  The clinical significance of hemoglobinopathies.

Authors:  M A Ali; S C Wong
Journal:  Can Fam Physician       Date:  1984-09       Impact factor: 3.275

2.  miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta.

Authors:  Duonan Yu; Camila O dos Santos; Guowei Zhao; Jing Jiang; Julio D Amigo; Eugene Khandros; Louis C Dore; Yu Yao; Janine D'Souza; Zhe Zhang; Saghi Ghaffari; John Choi; Sherree Friend; Wei Tong; Jordan S Orange; Barry H Paw; Mitchell J Weiss
Journal:  Genes Dev       Date:  2010-08-01       Impact factor: 11.361

3.  Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis.

Authors:  Edyta Glogowska; Eve R Schneider; Yelena Maksimova; Vincent P Schulz; Kimberly Lezon-Geyda; John Wu; Kottayam Radhakrishnan; Siobán B Keel; Donald Mahoney; Alison M Freidmann; Rachel A Altura; Elena O Gracheva; Sviatoslav N Bagriantsev; Theodosia A Kalfa; Patrick G Gallagher
Journal:  Blood       Date:  2017-07-17       Impact factor: 22.113

4.  Molecular basis for dominantly inherited inclusion body beta-thalassemia.

Authors:  S L Thein; C Hesketh; P Taylor; I J Temperley; R M Hutchinson; J M Old; W G Wood; J B Clegg; D J Weatherall
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  Dominantly inherited beta thalassaemia intermedia caused by a new single nucleotide deletion in exon 2 of the beta globin gene: Hb morgantown (beta91 CTG>CG).

Authors:  H-Y Luo; W Tang; S H Eung; J E Coad; P Canfield; F Keller; E H Crowell; M H Steinberg; D H K Chui
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

6.  Hemoglobin Indianapolis (beta 112[G14] arginine). An unstable beta-chain variant producing the phenotype of severe beta-thalassemia.

Authors:  J G Adams; L A Boxer; R L Baehner; B G Forget; G A Tsistrakis; M H Steinberg
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Clinical and haematological evaluation of beta thalassaemia intermedia characterised by unusually low Hb F and increased Hb A2: beta thalassaemia intermedia II.

Authors:  A Gurgey; S Kayin; E Kansu; C Altay
Journal:  J Med Genet       Date:  1985-06       Impact factor: 6.318

8.  beta+-Thalassemia intermedia with low HbF.

Authors:  M A Zago; F F Costa; C Bottura
Journal:  Klin Wochenschr       Date:  1983-01-17

Review 9.  Molecular basis of β thalassemia and potential therapeutic targets.

Authors:  Swee Lay Thein
Journal:  Blood Cells Mol Dis       Date:  2017-06-20       Impact factor: 3.039

Review 10.  Hemoglobin variants: biochemical properties and clinical correlates.

Authors:  Christopher S Thom; Claire F Dickson; David A Gell; Mitchell J Weiss
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.